BITF Shareholders Have the Right to Lead the Bitfarms Ltd. Securities Lawsuit
Shareholders who purchased the Company's securities between March 21, 2023 and December 9, 2024, inclusive (the 'Class Period'), are encouraged to contact the firm before July 8, 2025.
CASE DETAILS: The complaint alleges that the Company made false and misleading statements to the market concerning whether Bitfarms failed to maintain adequate controls over financial reporting. The Company incorrectly accounts for proceeds from the sale of digital assets as the result of operating activities, not investing activities. The Company overstated its remediation of material weaknesses in its internal controls. The Company misstated items in its previous financial statements due to these weaknesses.
If you are a shareholder who suffered a loss, contact us to participate.
WHY DJS LAW GROUP? DJS Law Group's primary focus is to enhance investor return through balanced counseling and aggressive advocacy. We specialize in securities class actions, corporate governance litigation, and domestic/international M&A appraisals. Our clients are some of the largest and most sophisticated hedge funds and alternative asset managers in the world. The litigation claims of our clients are extraordinarily valuable assets that demand respect, focus, and results.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
CONTACT:David J. SchwartzDJS Law Group274 White Plains Road, Suite 1 Eastchester, NY 10709Phone: 914-206-9742Email: David@djslawllp.com
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New Straits Times
7 minutes ago
- New Straits Times
Stock markets cautious with eyes on Ukraine talks, US rates
NEW YORK: European stock markets rose while Wall Street mostly retreated Tuesday as investors warily eyed signs of progress in talks to end Russia's war in Ukraine. Markets were also waiting for a key speech by the US Federal Reserve chief this week for clues on interest rate cuts that could bolster the world's biggest economy. Hopes for a Ukraine breakthrough rose after US President Donald Trump said he spoke by phone with Russian counterpart Vladimir Putin, following a meeting with Ukrainian President Volodymyr Zelensky and European leaders at the White House. Zelensky said he was ready for what would be his first face-to-face talks with Putin since Russia's invasion nearly three and a half years ago. Wall Street mostly pulled back, with the Nasdaq tumbling 1.5 percent and S&P 500 losing 0.6 percent. The Dow closed flat. London, Paris and Frankfurt stocks all closed higher following a lackluster session for Asian stock markets. Defense stocks fell sharply as chances grew for a breakthrough in Ukraine peace talks, with Germany's Rheinmetall dropping 4.7 percent and France's Thales down 4.1 percent. Investors were also eagerly awaiting a speech on Friday by Fed Chair Jerome Powell at the annual retreat of global central bankers in Jackson Hole, Wyoming. Traders hope Powell will provide more clues about a widely expected interest rate cut at the Fed's next policy meeting in September, after data last week provided a mixed picture about inflation. "Markets seem to be exercising some caution ahead of the Jackson Hole meeting later this week and as talks over a peace agreement between Russia and Ukraine remain inconclusive," said AJ Bell's head of financial analysis Danni Hewson. Oil prices, which have been volatile for several days -- Russia is a major crude producer -- retreated after gains on Monday. "Oil prices have dropped a little as a deal edges closer, given that it's likely to lead to an easing of sanctions on Russia energy imports, increasing supplies on global markets," said Susannah Streeter, head of money and markets at Hargreaves Lansdown. Japan's Nikkei briefly hit a record before retreating to close down 0.4 percent. Shanghai ended flat while Hong Kong, Sydney and Seoul fell, and Singapore, Bangkok and Mumbai edged up. Among individual companies, Intel shares advanced around 7.0 percent in New York after Japan-based tech investment giant SoftBank said it would invest $2 billion in the troubled US chip giant. White House Press Secretary Karoline Leavitt confirmed Tuesday that the US Commerce Department was "ironing out the details" on a deal with the company, as the government seeks a stake in Intel in exchange for grants.
Malaysian Reserve
26 minutes ago
- Malaysian Reserve
Global Personal Care Contract Manufacturing Market to Cross USD 40 Billion by 2032
Rising demand for personal care and cosmetic products is a major factor driving the growth of personal care contract manufacturing. This trend is primarily supported by higher per capita income, which is increasing consumer spending on beauty and personal care goods. Moreover, government initiatives promoting the use of natural and organic products are further accelerating market expansion. LAS VEGAS, Aug. 19, 2025 /PRNewswire/ — DelveInsight's Personal Care Contract Manufacturing Market Insights report provides the current and forecast market analysis, individual leading personal care contract manufacturing companies' market shares, challenges, personal care contract manufacturing market drivers, barriers, trends, and key market personal care contract manufacturing companies in the market. Key Takeaways from the Personal Care Contract Manufacturing Market Report As per DelveInsight estimates, North America is anticipated to dominate the global personal care contract manufacturing market during the forecast period. In the application segment of the personal care contract manufacturing market, the skin care category accounted for the largest market share in 2024. Notable personal care contract manufacturing companies such as Albea Group, McBride, Colep Consumer Products, PLZ Corp., Voyant Beauty, Formula Corp., INTERCOS S.P.A., H.S.A. Hair Styling Applications S.p.A., Clarion Cosmetics, COMECER S.p.A., Novo Nordisk A/S, Siegfried Holding AG, Aenova Group, SED Pharma, 3P innovation Ltd., FUJIFILM Holdings Corporation, BRAM-COR SPA, and groninger & Co. GmbH, Danaher Corporation, Syntegon Technology GmbH, and several others, are currently operating in the personal care contract manufacturing market. In October 2024, Evonik and Kolmar Cosmetics (Wuxi) Co., Ltd. officially entered into a strategic partnership agreement in Wuxi, China. This collaboration is focused on driving innovation in raw materials by developing sustainable ingredients, advanced sun care solutions, color cosmetics, and high-performance active ingredients. The partnership also emphasizes novel formulation research, aiming to enhance product development capabilities and support the growing demand for innovative and eco-friendly personal care solutions. To read more about the latest highlights related to the personal care contract manufacturing market, get a snapshot of the key highlights entailed in the Global Personal Care Contract Manufacturing Market Report Personal Care Contract Manufacturing Overview Personal care contract manufacturing refers to outsourcing the production of personal care and cosmetic products to specialized third-party manufacturers. This approach allows brand owners to focus on core activities such as marketing, distribution, and innovation while leveraging the expertise, infrastructure, and regulatory compliance capabilities of contract manufacturers. The industry covers a wide range of products, including skincare, haircare, oral care, and cosmetics, offering services like formulation development, product testing, packaging, and labeling. With increasing consumer demand for high-quality, innovative, and safe products, contract manufacturers are investing in advanced technologies, sustainable practices, and flexible production capacities to cater to both emerging and established brands. Personal Care Contract Manufacturing Market Insights In 2024, North America dominated the personal care contract manufacturing market, driven by increasing consumer expenditure on personal care and cosmetic products, higher disposable incomes, and rising demand for innovative, premium-quality solutions. The region is also experiencing a notable uptick in collaborations and partnerships among major industry players, aimed at creating advanced and diverse product portfolios. Additionally, companies are expanding their service offerings to align with the evolving needs of brands. For example, in February 2024, Aptar Beauty introduced Turnkey Solutions by Aptar™, a comprehensive service integrating advanced formulations, in-house laboratory capabilities, and a network of expert partners with Aptar's established expertise in filling and distribution, enabling end-to-end support for personal care product development. As a result, the combined effect of surging demand for personal care products and increased consumer spending on cosmetics is anticipated to substantially drive market growth in North America between 2025 and 2032. To know more about why North America is leading the market growth in the personal care contract manufacturing market, get a snapshot of the Personal Care Contract Manufacturing Market Outlook Personal Care Contract Manufacturing Market Dynamics The personal care contract manufacturing market is experiencing robust growth, driven by rising consumer demand for high-quality, innovative, and customized personal care products. As brand owners increasingly focus on marketing, brand building, and customer engagement, many are outsourcing formulation, production, and packaging to specialized contract manufacturers. This shift allows companies to reduce capital expenditure on manufacturing facilities and leverage the expertise, technology, and scalability of third-party partners. Growing consumer expectations for product variety, sustainable formulations, and shorter launch cycles are further fueling the reliance on contract manufacturing in this sector. One of the key demand drivers is the growing preference for natural, organic, and clean-label products. With heightened awareness of ingredient safety and environmental sustainability, consumers are pushing brands to reformulate products with eco-friendly, cruelty-free, and non-toxic ingredients. Contract manufacturers are responding by investing in R&D capabilities, green chemistry processes, and sustainable packaging solutions to meet regulatory requirements and consumer expectations. Additionally, the rising purchasing power in emerging economies and the premiumization trend in mature markets are creating new growth opportunities for both global and regional contract manufacturing players. From a supply-side perspective, the market is shaped by technological advancements and operational efficiencies. Automation, advanced formulation technologies, and flexible manufacturing systems enable contract manufacturers to cater to both small-batch niche products and large-scale mass-market items. Strategic partnerships between brands and manufacturers are increasingly common, enabling faster time-to-market and shared innovation. However, the competitive landscape is intense, with manufacturers differentiating themselves through quality certifications, compliance with Good Manufacturing Practices (GMP), and the ability to offer end-to-end services, from product ideation to distribution-ready packaging. Challenges in the market include stringent regulatory environments and fluctuating raw material costs. Personal care products often require adherence to strict quality and safety regulations, which vary across regions and product categories. This necessitates significant investment in compliance infrastructure, documentation, and testing capabilities. Volatility in the prices of natural oils, botanical extracts, and other raw materials can also affect production costs and profit margins. Furthermore, the rise of private-label brands has intensified competition, compelling contract manufacturers to continuously innovate and maintain cost efficiencies. Looking ahead, the personal care contract manufacturing market is poised for sustained expansion, with digitalization, customization, and sustainability as key strategic pillars. E-commerce growth is driving demand for smaller, more diverse product lines, while the rise of direct-to-consumer (DTC) beauty brands creates fresh opportunities for agile manufacturing models. Players that can offer flexible, compliant, and sustainable solutions while fostering collaborative partnerships with brand owners are likely to gain a competitive edge in this dynamic market landscape. Get a sneak peek at the personal care contract manufacturing market dynamics @ Personal Care Contract Manufacturing Market Dynamics Analysis Report Metrics Details Coverage Global Study Period 2022–2032 Personal Care Contract Manufacturing Market CAGR ~8% Personal Care Contract Manufacturing Market Size by 2032 ~USD 42 Billion Key Personal Care Contract Manufacturing Companies Albea Group, McBride, Colep Consumer Products, PLZ Corp., Voyant Beauty, Formula Corp., INTERCOS S.P.A., H.S.A. Hair Styling Applications S.p.A., Clarion Cosmetics, COMECER S.p.A., Novo Nordisk A/S, Siegfried Holding AG, Aenova Group, SED Pharma, 3P innovation Ltd., FUJIFILM Holdings Corporation, BRAM-COR SPA, and groninger & Co. GmbH, Danaher Corporation, Syntegon Technology GmbH, and others Personal Care Contract Manufacturing Market Assessment Personal Care Contract Manufacturing Market Segmentation Personal Care Contract Manufacturing Market Segmentation By Offering: Products (Tubes, Jars & Bottles, Spray, and Others) and Services Personal Care Contract Manufacturing Market Segmentation By Formulation: Liquids, Powders, Aerosols, Creams, and Others Personal Care Contract Manufacturing Market Segmentation By Application: Skin Care, Hair Care, and Others Personal Care Contract Manufacturing Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of World Which MedTech key players in the personal care contract manufacturing market are set to emerge as the trendsetter explore @ Personal Care Contract Manufacturing Companies Table of Contents 1 Personal Care Contract Manufacturing Market Report Introduction 2 Personal Care Contract Manufacturing Market Executive Summary 3 Competitive Landscape 4 Regulatory Analysis 5 Personal Care Contract Manufacturing Market Key Factors Analysis 6 Personal Care Contract Manufacturing Market Porter's Five Forces Analysis 7 Personal Care Contract Manufacturing Market Layout 8 Personal Care Contract Manufacturing Market Company and Product Profiles 9 KOL Views 10 Project Approach 11 About DelveInsight 12 Disclaimer & Contact Us Interested in knowing the personal care contract manufacturing market by 2032? Click to get a snapshot of the Personal Care Contract Manufacturing Market Trends Related Reports Contract Development Manufacturing Organization Market Contract Development Manufacturing Organization Market Insights, Competitive Landscape, and Market Forecast – 2032 report delivers an in-depth understanding of the market trends, market drivers, market barriers, and key CDMO companies, including Patheon (Thermo Fisher Scientific), Catalent,Inc, Laboratoire Elaiapharm, The Lubrizol Corporation, Cambrex Corporation, Recipharm (EQT), Merck & Co., Inc, AGC Biologics, Nerpharma S.r.l, Pfizer CenterOne (Pfizer Inc), EMERGENT, Onyx Scientific Limited, Lonza, Siegfried Holding AG, CordenPharma International, FUJIFILM Diosynth Biotechnologies, Samsung Biologics, Delpharm, Center for Breakthrough Medicines, and WuXi Biologics, among others. Biopharmaceuticals Contract Manufacturing Market Biopharmaceuticals Contract Manufacturing Market Insights, Competitive Landscape, and Market Forecast – 2032 report delivers an in-depth understanding of the market trends, market drivers, market barriers, and key biopharmaceuticals contract manufacturing companies, including Boehringer Ingelheim International GmbH, Lonza, Rentschler Biopharma SE, BINEX Co., Ltd., INCOG BioPharma Service, FUJIFILM Diosynth Biotechnologies U.S.A. Inc., Novartis AG, ProBioGen AG, TOYOBO CO., LTD., Samsung Biologics, Thermo Fisher Scientific, Inc., AbbVie, Inc., WuXi Biologics, AGC Biologics, ADMA Biologics, Inc., Baxter BioPharma Solutions (Baxter), iBio., Catalent, Inc., Cambrex Corporation, Pfizer Inc., among others. Biologics Drug Substance Fill and Finish Manufacturing Market Biologics Drug Substance Fill and Finish Manufacturing Market Insight, Competitive Landscape, and Market Forecast – 2032 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key biologics drug substance fill and finish manufacturing companies, including JOINN Biologics, Pharmaron, Symbiosis Pharmaceutical Services, AGC Biologics, INCOG BioPharma Services, CPC, Eurofins Scientific, among others. Biologics Drug Substance Manufacturing Market Biologics Drug Substance Manufacturing Market Insight, Competitive Landscape, and Market Forecast – 2032 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key biologics drug substance manufacturing companies, including Lonza, Pfizer Inc., Catalent, Inc., Boehringer Ingelheim International GmbH, Samsung Biologics, WuXi AppTec, Thermo Fisher Scientific Inc., Asahi Kasei Corporation, Recipharm AB, Evotec, Novo Nordisk A/S, Siegfried Holding AG, Enzene Biosciences Ltd., Forge Biologics, BeiGene LTD., FUJIFILM Holdings Corporation, TOYOBO CO., LTD., AJINOMOTO CO., INC., Biocon, Eurofins Scientific, among others. About DelveInsight DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Contact UsShruti Thakur info@ +14699457679https:// Logo: View original content:
The Star
3 hours ago
- The Star
Nasdaq tumbles as Jackson Hole jitters hit tech stocks
The Dow rose 10.45 points, roughly flat, to 44,922.27, the S&P 500 lost 37.78 points, or 0.59%, to 6,411.37 and the Nasdaq lost 314.82 points, or 1.46%, to 21,314.95. NEW YORK: The Nasdaq and S&P 500 slid on Tuesday driven by tech stocks, as investors gear up for what Federal Reserve chair Jerome Powell will say about the path of interest rates at a key conference later in the week. The Nasdaq fell as megacaps lost, after having rallied for much of the year. Nvidia fell 3.5%, the biggest drop in nearly four months. The key event this week is the Fed's annual symposium at Jackson Hole, Wyoming, from Aug. 21-23, where Powell's comments will be scrutinized for any clues on the central bank's outlook on the economy and monetary policy. "It seems like folks are hedging a little going into Jackson Hole, thinking Powell might be more hawkish than markets currently appreciate," said James Cox, managing partner at Harris Financial Group. Interest rate futures point to a total of two rate cuts this year worth 25 basis points each, with the first expected in September, according to data compiled by LSEG. Some market participants also expressed some concerns about AI-related stocks after OpenAI's CEO Sam Altman said they are in a bubble in an interview with "The Verge" late last week. The Dow Jones Industrial Average rose 10.45 points, roughly flat, to 44,922.27, the S&P 500 lost 37.78 points, or 0.59%, to 6,411.37 and the Nasdaq Composite lost 314.82 points, or 1.46%, to 21,314.95. Steve Sosnick, chief strategist at Interactive Brokers, said some investors are taking some profits from tech stocks and rotating into other sectors. "(This move) spills into the broader market because of those stocks' weight in major indices," he added. Still, six of the S&P 500 sectors rose. Real estate led the pack, up 1.8%, helped by better-than-expected housing data. On the other hand, technology and communications services lost over 1.9% and 1.2%, respectively. A Reuters poll showed on Tuesday that the S&P 500 will end 2025 just below current near-record levels, at 6,300 points, reflecting tempered optimism amid ongoing concerns over the economic impact of President Donald Trump's global tariffs and uncertainty surrounding Fed rate cuts. The blue-chip Dow briefly hit a record high on Tuesday, aided by a rise in Home Depot's shares after the retailer kept its annual forecasts intact. Home Depot rose 3.17% despite missing quarterly results estimates, while rival home-improvement chain Lowe's also gained 2.18%. Earnings from Lowe's and big-box retailers Walmart and Target later this week are now in focus as investors await more insight on the health of the American consumer. "Consumers are still not really spending at full speed ahead, they're a little bit cautious," said Peter Cardillo, chief market economist at Spartan Capital Securities. "They're waiting to see the full results of the tariffs' impact on the upcoming holiday sales in a couple of months from now." Intel jumped roughly 7% after the chipmaker got a US$2 billion capital injection from Japan's SoftBank Group. Palo Alto Networks rose 3.06% after the cybersecurity company forecast fiscal 2026 revenue and profit above estimates. Medtronic lost 3.13%, after the company said it would add two new directors to its board after Elliott Investment Management took a large stake in the medical-device maker. Advancing issues outnumbered decliners by a 1.06-to-1 ratio on the NYSE. There were 205 new highs and 62 new lows on the NYSE. The S&P 500 posted 13 new 52-week highs and one new low while the Nasdaq Composite recorded 56 new highs and 88 new lows. — Reuters
